Latest Breaking News On - லிலியன் லூ - Page 1 : vimarsana.com

In memoriam May 3, 2021 Dr John C Martin, former chairman and CEO of Gilead Sciences, Inc, passed away on March 30 in California at the age of 70. A true innovator, John transformed Gilead from a mid-sized player into a juggernaut in the virology space, pioneering a series of revolutionary single-pill treatments that effectively reduced HIV from a deadly pandemic to a disease that is now both preventable and controllable with highly effective antiretroviral medicines. Under his stewardship, Gilead created highly effective treatments for hepatitis B and revolutionized the treatment of the hepatitis C virus (HCV) with the launch of Sovaldi, the first oral treatment for HCV in 2013. This was followed by a series of even more effective treatments, which have reduced treatment duration to 12 weeks and cure rates to above 95 percent.

United statesJohn martinOsman khalid waheedSaeed hamidLillian louJohnc martinJohnc martin foundationGilead access programAga khan universityDepartment of medicineGilead sciences incFerozsons laboratoriesGilead sciencesVoluntary licensingPrime ministerViral hepatitis elimination